The reverse remodeling response to sacubitril/valsartan therapy in heart failure with reduced ejection fraction

Feasibility and Association of Neurohumoral Blocker Up-titration After Cardiac Resynchronization Therapy

(2017) Pieter Martens et al.   JOURNAL OF CARDIAC FAILURE

Heart Failure with Myocardial Recovery - The Patient Whose Heart Failure Has Improved: What Next?

(2017) Petra Nijst et al.   PROGRESS IN CARDIOVASCULAR DISEASES

Sacubitril–Valsartan in Heart Failure: Why Are More Physicians Not Prescribing It?

(2016) Milton Packer et al.   ANNALS OF INTERNAL MEDICINE

Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition

(2016) Scott A. Hubers et al.   CIRCULATION

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN HEART JOURNAL

Kicking the tyres of a heart failure trial: physician response to the approval of sacubitril/valsartan in the USA

(2016) Milton Packer   EUROPEAN JOURNAL OF HEART FAILURE

The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan

(2016) Pardeep S Jhund et al.   HEART

Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

(2016) Sherif F. Nagueh et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

(2015) Roberto M. Lang et al.   European Heart Journal-Cardiovascular Imaging

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

(2014) John J.V. McMurray et al.   NEW ENGLAND JOURNAL OF MEDICINE